2014

FDA approval and launch of Monovisc, the first non-animal sourced hyaluronic acid single-injection treatment for knee osteoarthritis in the United States.

First surgery performed using the ToeMotion® Total Toe System, designed to restore mobility and maintain native biomechanics1.